Stressgen (VSE: SSB) Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Stressgen (VSE: SSB)

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: nigel bates who wrote (150)	11/15/2000 4:25:23 PM
From: Heat Shock	Read Replies (1) of 236

Nigel: no problem. I respect the quality of your posts. Please post anything you find on StressGen. I remember some other things from the conference call (800-558-5253 with reservation number 16828978). StressGen CEO Korpolinsky said they have enough cash to get the first product to market without further financing. Blimey, if they could do that and also partner with big pharma on HIV, hepatitis or allergy/asthma or some other product candidate, then StressGen would really roll. Korpolinsky said that if StressGen decided to partner HspE7, they could get a good deal (like 50/50) because the therapy is in Phase III and they have the cash to help finish Phase III. He said they are seeking big pharma partners in your neck of the woods (Europe) and also in North America. He said they have had discussions and they are going to talk to 2 other pharmas shortly- no specifics. Heat.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next